Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 55 entries
View as:

Anterior Stromal Changes After PRK by Using Intraoperative Mitomicin C

Phase: N/A Priority: Normal
NCT ID: NCT00599950 Org: User:
Start: 01/31/07 End: 11/30/07 Due: 11/30/08

Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.

Phase: N/A Priority: Normal
NCT ID: NCT00802269 Org: User:
Start: 03/31/08 End: 11/30/08 Due: 11/30/09

Use of Fibrin Glue in Vitreoretinalsurgery

Phase: N/A Priority: Normal
NCT ID: NCT01022164 Org: User:
Start: 05/31/09 End: 04/30/10 Due: 04/30/11

Comparison High-density Silicone Oils in Retinal Detachment

Phase: N/A Priority: Normal
NCT ID: NCT00403702 Org: User:
Start: 08/31/06 End: 08/31/07 Due: 08/31/08

Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00563043 Org: User:
Start: 10/31/07 End: 02/29/08 Due: 02/28/09

Epi-LASIK : A Confocal Microscopy Analysis of the Corneal Epithelium and Anterior Stroma.

Phase: N/A Priority: Normal
NCT ID: NCT00599690 Org: User:
Start: 01/31/06 End: 09/30/07 Due: 09/30/08

Bevacizumab and Retinal Vascular Occlusions

Phase: N/A Priority: Normal
NCT ID: NCT00347711 Org: User:
Start: 06/30/06 End: 06/30/06 Due: 06/30/07

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

Phase: N/A Priority: Normal
NCT ID: NCT05636579 Org: User:
Start: 11/08/22 End: 12/31/25 Due: 12/31/26

Retrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial

Phase: N/A Priority: Normal
NCT ID: NCT04942002 Org: User:
Start: 06/15/21 End: 09/15/23 Due: 09/15/24

Avastin for Post-photocoagulation Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT00801866 Org: User:
Start: 12/31/08 End: 12/31/08 Due: 12/31/09

Vascular Endothelial Growth Factor in Stage V ROP

Phase: N/A Priority: Normal
NCT ID: NCT00500396 Org: User:
Start: 03/31/07 End: 06/30/07 Due: 06/30/08

Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study

Phase: N/A Priority: Normal
NCT ID: NCT00600301 Org: User:
Start: 01/31/08 End: 01/31/08 Due: 01/31/09

Safety and Efficacy of Low-Fluence PRP for PDR

Phase: N/A Priority: Normal
NCT ID: NCT01737957 Org: User:
Start: 11/30/12 End: 03/31/13 Due: 03/31/14

POSTERIOR SUB-TENON'S Avastin

Phase: N/A Priority: Normal
NCT ID: NCT00567372 Org: User:
Start: 06/30/08 End: 06/30/09 Due: 06/30/10

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Phase: N/A Priority: Normal
NCT ID: NCT00406172 Org: User:
Start: 11/30/06 End: 11/30/06 Due: 11/30/07

Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation

Phase: N/A Priority: Normal
NCT ID: NCT00801905 Org: User:
Start: 08/31/08 End: 03/31/09 Due: 03/31/10

Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT00347399 Org: User:
Start: 03/31/06 End: 06/30/07 Due: 06/30/08

Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT05736081 Org: User:
Start: 02/15/18 End: 06/30/19 Due: 06/30/20

Study to Assess Safety and Tolerability of EO2002

Phase: N/A Priority: Normal
NCT ID: NCT05587205 Org: User:
Start: 08/30/22 End: 12/01/25 Due: 12/01/26

Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00417833 Org: User:
Start: 12/31/05 End: 07/31/06 Due: 07/31/07

HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population

Phase: N/A Priority: Normal
NCT ID: NCT00600236 Org: User:
Start: 09/30/04 End: 01/31/08 Due: 01/31/09

A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis

Phase: N/A Priority: Normal
NCT ID: NCT00499551 Org: User:
Start: 09/30/07 End: 09/30/09 Due: 09/30/10

Unilateral Bevacizumab for Bilateral Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT00496405 Org: User:
Start: 04/30/07 End: 10/31/07 Due: 10/31/08

Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01820520 Org: User:
Start: 01/31/13 End: 02/28/14 Due: 02/28/15

Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy

Phase: N/A Priority: Normal
NCT ID: NCT00347698 Org: User:
Start: 03/31/06 End: 08/31/07 Due: 08/31/08